Finsbury Emerging Biotechnology Tst
02 October 2006
FINSBURY EMERGING BIOTECHNOLOGY TRUST PLC
THIS ANNOUNCEMENT REPLACES RNS.7900J RELEASED THIS MORNING
CONTACT TELEPHONE NUMBER CORRECTED
2 October 2006
Finsbury Emerging Biotechnology Trust PLC - Giving of Protective Notice
The directors of Finsbury Emerging Biotechnology Trust PLC (the "Company")
hereby announce that the Company has given to its Manager, Close Finsbury Asset
Management Limited ("CFAM"), protective notice to terminate the existing
Management, Administrative and Secretarial Services Agreement between the
Company and CFAM so that it will expire on 2 October 2007, subject to the
entitlement of the Company to withdraw the notice at any time before its expiry.
Enquiries:
John Sclater, Chairman
Tel. 01273 400450
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.